Schröder CH - Search Results

1

The clinical spectrum of type IV collagen mutations.

Lemmink HH, Schröder CH, Monnens LA, Smeets HJ. Lemmink HH, et al. Among authors: schroder ch. Hum Mutat. 1997;9(6):477-99. doi: 10.1002/(SICI)1098-1004(1997)9:6<477::AID-HUMU1>3.0.CO;2-#. Hum Mutat. 1997. PMID: 9195222 Review.

2

Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation.

van der Loop FT, Heidet L, Timmer ED, van den Bosch BJ, Leinonen A, Antignac C, Jefferson JA, Maxwell AP, Monnens LA, Schröder CH, Smeets HJ. van der Loop FT, et al. Among authors: schroder ch. Kidney Int. 2000 Nov;58(5):1870-5. doi: 10.1111/j.1523-1755.2000.00358.x. Kidney Int. 2000. PMID: 11044206

3

Identification of four novel mutations in the COL4A5 gene of patients with Alport syndrome.

Lemmink HH, Schröder CH, Brunner HG, Nelen MR, Zhou J, Tryggvason K, Haagsma-Schouten WA, Roodvoets AP, Rascher W, van Oost BA, et al. Lemmink HH, et al. Among authors: schroder ch. Genomics. 1993 Aug;17(2):485-9. doi: 10.1006/geno.1993.1351. Genomics. 1993. PMID: 8406498

4

Aberrant splicing of the COL4A5 gene in patients with Alport syndrome.

Lemmink HH, Kluijtmans LA, Brunner HG, Schröder CH, Knebelmann B, Jelínková E, van Oost BA, Monnens LA, Smeets HJ. Lemmink HH, et al. Among authors: schroder ch. Hum Mol Genet. 1994 Feb;3(2):317-22. doi: 10.1093/hmg/3.2.317. Hum Mol Genet. 1994. PMID: 8004101

5

Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome.

Lemmink HH, Mochizuki T, van den Heuvel LP, Schröder CH, Barrientos A, Monnens LA, van Oost BA, Brunner HG, Reeders ST, Smeets HJ. Lemmink HH, et al. Among authors: schroder ch. Hum Mol Genet. 1994 Aug;3(8):1269-73. doi: 10.1093/hmg/3.8.1269. Hum Mol Genet. 1994. PMID: 7987301

6

Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.

Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schröder CH, Smeets HJ, et al. Mochizuki T, et al. Among authors: schroder ch. Nat Genet. 1994 Sep;8(1):77-81. doi: 10.1038/ng0994-77. Nat Genet. 1994. PMID: 7987396

7

The urinary excretion of total hydroxylysine and its glycosides in normal persons, and in patients suffering from Alport's syndrome--contribution of the peptide-bound fraction.

Schröder CH, Monnens LA, van Lith-Zanders HM, Trijbels JM, Veerkamp JH. Schröder CH, et al. Nephron. 1987;47(4):253-7. doi: 10.1159/000184519. Nephron. 1987. PMID: 3696326

8

Hereditary disorders of the glomerular basement membrane.

Smeets HJ, Knoers VV, van de Heuvel LP, Lemmink HH, Schröder CH, Monnens LA. Smeets HJ, et al. Among authors: schroder ch. Pediatr Nephrol. 1996 Dec;10(6):779-88. doi: 10.1007/s004670050217. Pediatr Nephrol. 1996. PMID: 8971907 Review.

9

Identification of COL4A5 defects in Alport's syndrome by immunohistochemistry of skin.

van der Loop FT, Monnens LA, Schröder CH, Lemmink HH, Breuning MH, Timmer ED, Smeets HJ. van der Loop FT, et al. Among authors: schroder ch. Kidney Int. 1999 Apr;55(4):1217-24. doi: 10.1046/j.1523-1755.1999.00357.x. Kidney Int. 1999. PMID: 10200983

10

Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.

Lemmink HH, Nillesen WN, Mochizuki T, Schröder CH, Brunner HG, van Oost BA, Monnens LA, Smeets HJ. Lemmink HH, et al. Among authors: schroder ch. J Clin Invest. 1996 Sep 1;98(5):1114-8. doi: 10.1172/JCI118893. J Clin Invest. 1996. PMID: 8787673 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results